Literature DB >> 10320113

A prognostic rule for elderly patients admitted with community-acquired pneumonia.

H A Conte1, Y T Chen, W Mehal, J D Scinto, V J Quagliarello.   

Abstract

PURPOSE: We sought to identify admission characteristics predicting mortality in elderly patients hospitalized with community-acquired pneumonia and to develop a prognostic staging system and discriminant rule. PATIENTS AND METHODS: We retrospectively analyzed data from 2,356 patients aged > or = 65 years admitted with community-acquired pneumonia. Multivariable analyses of a derivation cohort (n = 1,000) identified characteristics associated with hospital mortality. A staging system and discriminant rule based on these characteristics were tested in a validation cohort (n = 1,356). Our discriminant rule was compared with a rule formulated from a heterogeneous adult population with community-acquired pneumonia.
RESULTS: Hospital mortality rates were 9% (derivation cohort) and 12% (validation cohort). We identified five independent predictors of mortality: age > or = 85 years [odds ratio 1.8 (95% confidence interval 1.1-3.1)], comorbid disease [odds ratio 4.1 (2.1-8.1)], impaired motor response [odds ratio 2.3 (1.4-3.7)], vital sign abnormality [odds ratio 3.4 (2.1-5.4)], and creatinine level > or = 1.5 mg/dL [odds ratio 2.5 (1.5-4.2)]. These variables stratified patients into four distinct stages with increasing mortality in the derivation cohort (Stage 1, 2%; Stage 2, 7%; Stage 3, 22%; Stage 4, 45%; P = 0.001) as well as in the validation cohort (Stage 1, 4%; Stage 2, 11%; Stage 3, 23%; Stage 4, 41%; P = 0.001). The discriminant rule developed from the derivation cohort had greater overall accuracy (77.1%) in the validation cohort than a rule formulated from a heterogeneous adult population (68.0%, P = 0.001).
CONCLUSION: Elderly patients with community-acquired pneumonia have characteristics at admission that can predict mortality. Our staging system and discriminant rule improve prognostic stratification of these patients.

Entities:  

Mesh:

Year:  1999        PMID: 10320113     DOI: 10.1016/s0002-9343(98)00369-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  24 in total

1.  Severity prediction rules in community acquired pneumonia: a validation study.

Authors:  W S Lim; S Lewis; J T Macfarlane
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

2.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

3.  Prognostic factors for mortality due to pneumonia among adults from different age groups in Singapore and mortality predictions based on PSI and CURB-65.

Authors:  Zoe Xiaozhu Zhang; Yang Yong; Wan C Tan; Liang Shen; Han Seong Ng; Kok Yong Fong
Journal:  Singapore Med J       Date:  2017-08-14       Impact factor: 1.858

Review 4.  Management of community-acquired pneumonia in older adults.

Authors:  Antonella F Simonetti; Diego Viasus; Carolina Garcia-Vidal; Jordi Carratalà
Journal:  Ther Adv Infect Dis       Date:  2014-02

5.  Clinical features of spinal infection in individuals older than eighty years.

Authors:  Hideki Nagashima; Yoshiro Nanjo; Atsushi Tanida; Toshiyuki Dokai; Ryota Teshima
Journal:  Int Orthop       Date:  2011-12-22       Impact factor: 3.075

Review 6.  Influenza vaccinations: who needs them and when?

Authors:  Eelko Hak; Arno W Hoes; Theo J M Verheij
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Evaluation of pneumonia severity and acute physiology scores to predict ICU admission and mortality in patients hospitalized for influenza.

Authors:  Matthew P Muller; Allison J McGeer; Kazi Hassan; John Marshall; Michael Christian
Journal:  PLoS One       Date:  2010-03-05       Impact factor: 3.240

8.  Validation of predictive rules and indices of severity for community acquired pneumonia.

Authors:  S Ewig; A de Roux; T Bauer; E García; J Mensa; M Niederman; A Torres
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

Review 9.  Improving outcomes of elderly patients with community-acquired pneumonia.

Authors:  Félix Gutiérrez; Mar Masiá
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 10.  Adherence to guidelines for community-acquired pneumonia: does it decrease cost of care?

Authors:  Patricia D Brown
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.